Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
Saved in:
| Date: | 2018 |
|---|---|
| Main Authors: | L. K. Sokolova, V. M. Pushkarev, Yu. B. Belchina, V. V. Pushkarev, T. S. Vatseba, M. D. Tronko |
| Format: | Article |
| Language: | English |
| Published: |
2018
|
| Series: | Reports of the National Academy of Sciences of Ukraine |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000901997 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effect of combined trea tment with insulin and metformin on 5'AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020)
by: T. S. Vatseba, et al.
Published: (2020)
Protein kinase Akt activity in human thyroid tumors
by: B. B. Guda, et al.
Published: (2016)
by: B. B. Guda, et al.
Published: (2016)
The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
by: L. K. Sokolova, et al.
Published: (2017)
by: L. K. Sokolova, et al.
Published: (2017)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Phospho-mTOR (Ser2481) colocalizes with condensed chromosomes during metaphase
by: V. R. Kosach, et al.
Published: (2016)
by: V. R. Kosach, et al.
Published: (2016)
The expression and the activation of protein kinase Akt/PKB in normal tissues, benign and highly differentiated malignant human thyroid tumors
by: B. B. Huda, et al.
Published: (2016)
by: B. B. Huda, et al.
Published: (2016)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Characteristic of mTOR signaling and its involvement in the regulation of cell movements through remodeling the cytoskeleton architecture
by: V. R. Kosach, et al.
Published: (2015)
by: V. R. Kosach, et al.
Published: (2015)
Characteristic of mTOR signaling and its involvement in the regulation of cell movements through remodeling the cytoskeleton architecture
by: Kosach, V.R., et al.
Published: (2015)
by: Kosach, V.R., et al.
Published: (2015)
PI3K/mTOR/S6K signaling pathway – new players and new functional links
by: Filonenko, V.V.
Published: (2013)
by: Filonenko, V.V.
Published: (2013)
PI3K/mTOR/S6K signaling pathway – new players and new functional links
by: V. V. Filonenko
Published: (2013)
by: V. V. Filonenko
Published: (2013)
PI3K/mTOR-dependent signaling pathway as a possible regulator of processing body assembly
by: Gudkova, D.O., et al.
Published: (2011)
by: Gudkova, D.O., et al.
Published: (2011)
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
The expression of Akt kinase in the heart ventricles under hypoxic preconditioning and myocardial remodeling
by: A. G. Portnichenko, et al.
Published: (2013)
by: A. G. Portnichenko, et al.
Published: (2013)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Absolute insulin insufficiency in different variants of diabetes mellitus
by: T. M. Tikhonova, et al.
Published: (2018)
by: T. M. Tikhonova, et al.
Published: (2018)
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024)
by: M. D. Tronko, et al.
Published: (2024)
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022)
by: M. D. Tronko, et al.
Published: (2022)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
The role of PPARs and his isoforms in the metabolic disorder related to insulin resistance and diabetes
by: N. A. Kravchenko, et al.
Published: (2011)
by: N. A. Kravchenko, et al.
Published: (2011)
Rational design of protein kinase inhibitors
by: Yarmoluk, S.M., et al.
Published: (2013)
by: Yarmoluk, S.M., et al.
Published: (2013)
Rational design of protein kinase inhibitors
by: S. M. Yarmoluk, et al.
Published: (2013)
by: S. M. Yarmoluk, et al.
Published: (2013)
Metformin as a modifier of the oxidative status of peripheral blood and the viability of human lymphocytes under the influence of ionizing radiation
by: O. A. Hlavin, et al.
Published: (2020)
by: O. A. Hlavin, et al.
Published: (2020)
Quinazoline inhibitors of protein kinase FGFR1
by: A. A. Hryshchenko, et al.
Published: (2010)
by: A. A. Hryshchenko, et al.
Published: (2010)
Prediction of protein-ligand binding sites modulating activity of MAST protein kinases
by: P. A. Karpov, et al.
Published: (2024)
by: P. A. Karpov, et al.
Published: (2024)
Fluorescent proteins using for lymphocyte activation assaying
by: H. A. Liubchenko, et al.
Published: (2013)
by: H. A. Liubchenko, et al.
Published: (2013)
Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Isolation and characterization of insulin receptor of plasma membranes of rat liver cells at type 2 diabetes model
by: T. I. Halenova, et al.
Published: (2014)
by: T. I. Halenova, et al.
Published: (2014)
Insulin resistance indexes in patients with ischemic cardiac disease without diabetes mellitus during statine treatment
by: O. Bondarenko, et al.
Published: (2016)
by: O. Bondarenko, et al.
Published: (2016)
Generation of monoclonal antibodies specific to ribosomal protein S6 kinase 1
by: L. O. Savinska, et al.
Published: (2012)
by: L. O. Savinska, et al.
Published: (2012)
Untitled
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
MARK activation in human blood mononuclear cells in types 1 and 2 diabetes
by: V. V. Pushkarov, et al.
Published: (2020)
by: V. V. Pushkarov, et al.
Published: (2020)
Effect of inhibitors serine/threonine protein kinases and protein phosphatases on mitosis progression of synchronized tobacco BY-2 cells
by: Ja. A. Sheremet, et al.
Published: (2012)
by: Ja. A. Sheremet, et al.
Published: (2012)
Influence of tyrosine proteine kinases inhibitor, genestein, on Agrobacterium – mediated plant transformation
by: V. Fedorchuk, et al.
Published: (2015)
by: V. Fedorchuk, et al.
Published: (2015)
Similar Items
-
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018) -
Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018) -
Effect of combined trea tment with insulin and metformin on 5'AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018) -
Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020) -
Protein kinase Akt activity in human thyroid tumors
by: B. B. Guda, et al.
Published: (2016)